"Meeting the cancer treatment needs of patients and their families in Burleson and other areas of Johnson County has been a major focus of The Center for Cancer & Blood Disorders for many years. Working in cooperation with Huguley Memorial Medical Center, our team of dedicated cancer specialists offers cancer services comparable to those found in any major city."

During the past decade, The Center for Cancer and Blood Disorders-Burleson conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Center for Cancer and Blood Disorders-Burleson" #1 collaborator was "American College of Surgeons" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "North Central Cancer Treatment Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "The Center for Cancer and Blood Disorders-Burleson" are "Breast Adenocarcinoma" (1 trials), "Clear Cell Renal Cell Carcinoma" (1 trials), "Hormone Receptor Positive" (1 trials), "Recurrent Renal Cell Carcinoma" (1 trials) and "Stage IA Breast Cancer AJCC v7" (1 trials). Many other conditions were trialed in "The Center for Cancer and Blood Disorders-Burleson" in a lesser frequency.

Most popular intervention types in "The Center for Cancer and Blood Disorders-Burleson" are "Drug" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "Anastrozole" (1 trials), "Bevacizumab" (1 trials), "Exemestane" (1 trials) and "Letrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Center for Cancer and Blood Disorders-Burleson" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Center for Cancer and Blood Disorders-Burleson". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Center for Cancer and Blood Disorders-Burleson, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Center for Cancer and Blood Disorders-Burleson, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".